
Akerna Corp. KERN
Quarterly report 2025-Q3
added 11-14-2025
Akerna Corp. Operating Income 2011-2026 | KERN
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income Akerna Corp.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -17.7 M | -19.2 M | -43.1 M | -33.4 M | -17.3 M | -12.5 M | -2.46 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -2.46 M | -43.1 M | -20.8 M |
Quarterly Operating Income Akerna Corp.
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.2 M | -2.23 M | -5.47 M | - | -10.2 M | -5.87 M | -1.56 M | - | -9.2 M | -2.68 M | -1.93 M | - | -3.71 M | -20.2 M | -19.9 M | - | -3.72 M | -6.05 M | -3.51 M | - | -5.52 M | -6.18 M | -5.52 M | -4.39 M | -2.4 M | -7.31 M | -2.92 M | -2.45 M | -1.71 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 7.2 M | -20.2 M | -5.31 M |
Operating Income of other stocks in the Health information services industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Cerner Corporation
CERN
|
708 M | - | - | $ 27.9 B | ||
|
Covetrus
CVET
|
-23 M | - | - | $ 2.94 B | ||
|
Computer Programs and Systems
CPSI
|
-42.6 M | - | 4.4 % | $ 133 M | ||
|
Accolade
ACCD
|
-46.8 M | - | 0.29 % | $ 206 M | ||
|
iCAD
ICAD
|
-6.27 M | - | - | $ 102 M | ||
|
Change Healthcare
CHNG
|
137 M | - | - | $ 9.03 B | ||
|
Evolent Health
EVH
|
3.64 M | $ 4.0 | -1.23 % | $ 375 M | ||
|
Health Catalyst
HCAT
|
-69.8 M | $ 2.39 | 0.42 % | $ 144 M | ||
|
Progyny
PGNY
|
15.8 M | $ 25.68 | -0.62 % | $ 2.2 B | ||
|
HealthStream
HSTM
|
21.3 M | $ 23.07 | -0.86 % | $ 701 M | ||
|
Schrödinger
SDGR
|
-209 M | $ 17.88 | 0.45 % | $ 1.3 B | ||
|
So-Young International
SY
|
-624 M | $ 2.56 | 1.59 % | $ 203 M | ||
|
Premier
PINC
|
1.12 M | $ 28.26 | - | $ 2.33 B | ||
|
MTBC
MTBC
|
9.12 M | - | -0.58 % | $ 51.7 M | ||
|
HealthEquity
HQY
|
118 M | $ 91.61 | -0.96 % | $ 7.84 B | ||
|
American Well Corporation
AMWL
|
-218 M | $ 4.91 | 2.29 % | $ 73.6 M | ||
|
10x Genomics
TXG
|
-265 M | $ 16.31 | 0.12 % | $ 1.91 B | ||
|
Allscripts Healthcare Solutions
MDRX
|
77.2 M | - | -10.39 % | $ 886 M | ||
|
OptimizeRx Corporation
OPRX
|
-26.4 M | $ 12.26 | -1.05 % | $ 210 M | ||
|
R1 RCM
RCM
|
146 M | - | - | $ 3.81 B | ||
|
GoodRx Holdings
GDRX
|
65.8 M | $ 2.71 | 0.74 % | $ 1.05 B | ||
|
Zhongchao
ZCMD
|
-341 K | $ 0.45 | -26.63 % | $ 2.34 M | ||
|
Omnicell
OMCL
|
337 K | $ 45.3 | -1.35 % | $ 2.09 B | ||
|
1Life Healthcare
ONEM
|
-243 M | - | - | $ 3.37 B | ||
|
Phreesia
PHR
|
-136 M | $ 16.92 | -0.65 % | $ 923 M | ||
|
NantHealth
NH
|
-51.3 M | - | -46.64 % | $ 10.4 M | ||
|
NextGen Healthcare
NXGN
|
12.8 M | - | - | $ 1.6 B | ||
|
Signify Health
SGFY
|
9.5 M | - | -0.02 % | $ 7.21 B | ||
|
Streamline Health Solutions
STRM
|
-8.03 M | - | - | $ 21.4 M | ||
|
Teladoc Health
TDOC
|
-1.02 B | $ 7.0 | - | $ 1.19 B | ||
|
Tabula Rasa HealthCare
TRHC
|
-69 M | - | - | $ 255 M | ||
|
Veeva Systems
VEEV
|
429 M | $ 223.23 | -0.63 % | $ 35.8 B | ||
|
SCWorx Corp.
WORX
|
-1.26 M | $ 0.19 | -5.66 % | $ 277 K |